Human serum albumin (HSA), the most prominent protein in plasma, is best known for its exceptional ligand binding capacity, the most strongly bound compounds being hydrophobic organic anions of medium size, long-chain fatty acids, haem and bilirubin. Smaller and less hydrophobic compounds (e.g. tryptophan) are held less strongly, but their binding can still be highly specific. For many compounds, HSA provides a depot so they will be available in quantities well beyond their solubility in plasma. Moreover, HSA abundance (concentration of 45 mg : mL 21 in the serum of human adults) makes it an important determinant of the pharmacokinetic behaviour of many drugs. In other cases, HSA holds some ligands in a strained orientation, allowing their metabolic modification, and renders potential toxins harmless by transporting them to disposal sites. HSA also accounts for most of the antioxidant capacity of human serum, either directly or by binding and carrying radical scavengers, or by sequestering transition metal ions with pro-oxidant activity. Finally, HSA acts as a nitric oxide depot and carrier, leading to covalent modification(s) of (macro)molecules [1 -8] .
The amino acid sequence of HSA shows the occurrence of three homologous domains, probably arising from divergent evolution of a degenerated ancestral gene followed by a fusion event. However, the three domains deduced from the primary structure do not correspond to domains found in the three-dimensional model. Rather, terminal regions of sequential domains contribute to the formation of interdomain helices linking domain I to II, and II to III, respectively. On the other hand, each domain is known to consist of two separate sub-domains, connected by a random coil. Therefore, HSA can be considered as an ensemble of four globular domains, namely IA, IB 1 IIA, IIB 1 IIIA, and IIIB, freely linked by extended random coils. It is thus reasonable to hypothesize allosteric conformational transition(s) occurring in HSA upon ligand binding. Note that the flexibility of the HSA structure allows it to adapt readily to ligands and that its three-domain design provides a variety of binding sites. In particular, the conformational adaptability of HSA involves more than the immediate vicinity of the binding site(s), affecting both the structure and the ligand binding properties of the whole HSA molecule [1 -11] .
The interaction of ligands with HSA occurs mainly in two regions. According to the Sudlow's nomenclature, bulky heterocyclic anions bind to site I (located in subdomain IIA), whereas site II (located in subdomain IIIA) is preferred by aromatic carboxylates with an extended conformation. Remarkably, ibuprofen, a nonsteroidal anti-inflammatory agent [12] , and warfarin, an anticoagulant drug [12] , are considered as stereotypical ligands for Sudlow's site II and Sudlow's site I, respectively [1, 9, 11, 13, 14] [1, [16] [17] [18] . Secondary binding clefts have been found for ibuprofen and warfarin to be located on domain I. Remarkably, the ibuprofen secondary site corresponds to the warfarin primary cleft (i.e. to Sudlow's site I) [1, 3, 11] . Moreover, multiple recognition sites for binding of anaesthetics, fatty acids, and triiodobenzoic acid to HSA have also been identified [2, 5, 6, 14, 19] .
Among hydrophobic molecules, haem binding to HSA is of peculiar relevance for the haem iron reuptake following hemolytic events [1, 20] . The haem binding site has been located primarily at the interface between domains I and II of HSA, while on domains II and III secondary binding clefts have been found [3, 7, 10] . The binding of this spectroscopically active label to HSA makes it possible to follow a number of events involving the holoprotein by taking advantage of electronic absorption spectroscopy, EPR spectroscopy and 1 H-NMR relaxometry [7, 8, 10, 21, 22] . Here, the effect of ibuprofen and warfarin on the electronic absorption spectroscopic and 1 H-NMR-relaxometric properties of ferric haem -human serum albumin (ferric HSAhaem) as well as on the EPR spectroscopic properties of ferrous nitrosylated haem -human serum albumin (ferrous HSA-haem-NO) is reported.
M A T E R I A L S A N D M E T H O D S
HSA, haem chloride, ibuprofen ( Fig. 1) , warfarin (see Fig. 1 ), and the NO-donor S-nitroso-N-acetylpenicillamine were from Sigma. Gaseous NO was purchased from Aldrich Chemical Co. All the other products were from Merck AG. All chemicals were of analytical or reagent grade and used without further purification.
Ferric HSA -haem was prepared by adding 0.83-M defect of ferric haem, dissolved in 1.0 Â 10 21 M KOH, to an HSA solution, in 1.0 Â 10 21 M phosphate buffer plus 1.0 Â 10 21 M NaCl, pH 7.0 [8, 21] . Both in the absence and presence of ibuprofen and warfarin, haem binds to HSA mostly at the high affinity site and virtually no free haem is present in solution (see [1, 8, 21] , and present study). Values of the apparent dissociation equilibrium constant (K d ) for haem binding to the HSA primary site are 1.3^0.2 Â 10 28 M in the absence of drugs, and 1.5^0.2 Â 10 27 M in the presence of ibuprofen and warfarin (5.0 Â 10 22 M) (see [1, 22, 23] and the present study).
Ferrous HSA-haem-NO was obtained under anaerobic conditions: (a) by sequential addition of a 10-M excess of sodium dithionite or sodium ascorbate and a 4-M excess of Binding of ibuprofen and warfarin to ferric HSA -haem was followed by electronic absorption spectroscopy at pH 7.0, in 1.0 Â 10 , were collected between 350 nm and 700 nm. The electronic absorption spectra were recorded in 1-mm to 1-cm path length cuvettes. The ibuprofen-and warfarin-induced electronic absorption spectroscopic transition of ferric HSA -haem was complete within the time to achieve the sample preparation (, 10 min). Test measurements performed after 2 h excluded slow kinetic effects. Binding of ibuprofen and warfarin to ferric HSA -haem was also followed by 1 H-NMR relaxometry at pH 7.0 (1.0 Â 10 21 M phosphate buffer plus 1.0 Â 10 21 M NaCl) and 25.0 8C.
1 H-NMR relaxometry of ferric HSA -haem (1.0 Â 10 23 M) in the absence and presence of ibuprofen and warfarin (1.0 Â 10 24 M to 1.0 Â 10 21 M) was investigated on a Stelar SpinMaster Spectrometer (Stelar S.n.c., Mede, PV, Italy). Water proton relaxation rate (R 1 ) measurements were obtained at 0.47 T (i.e. at 20 MHz proton Larmor frequency) by means of the InversionRecovery technique (16 experiments, four scans). Magnetization values were obtained by averaging the first 128 data points of the Free Induction Decay. A phase cycle (1x, -x, -x, 1x) was applied on the 908 observation pulse to cut off the y-scale receiver offset. A typical 908 pulse width was 3.5 ms. The t-values were increased linearly from a starting value corresponding to one-seventh of the estimated null-point (0.693/R 1 ), so that the null-point occurs on the middle of the inversion-recovery curve (seventh experiment). In the 16th experiment the Free Induction Decay is acquired after a single 908 pulse, to obtain the M 1 value [24] . The reproducibility in R 1 measurements waŝ 0.5%. The temperature was controlled by a Stelar VTC-91 airflow heater (Stelar S.n.c.), equipped with a copperconstantan thermocouple; the actual temperature in the probe head was measured with a Fluke 52k/j digital thermometer (Fluke AG, Zürich, Switzerland), with an uncertainty of^0.3 8C. Values of the paramagnetic contribution to the overall water solvent relaxation rate (R 1p ) were determined by subtracting from the observed relaxation rate (R obs 1 ) the blank relaxation rate value (R dia 1 ) measured for solutions containing HSA at the same concentration without the paramagnetic prosthetic group. Test measurements performed after 2 h excluded slow kinetic effects [7] .
Haem binding to HSA in the absence and presence of ibuprofen and warfarin was followed by electronic absorption spectroscopy (between 350 nm and 450 nm) at pH 7.0 (1.0 Â 10 21 M phosphate buffer plus 1.0 Â 10 21 M NaCl) and 25.0 8C [22] . The HSA concentration ranged between 3.0 Â 10 28 M and 2.0 Â 10 26 M, the haem concentration was 1.0 Â 10 27 M, and the ibuprofen and warfarin concentrations were 5.0 Â 10 22 M. The electronic absorption spectra were recorded in a 10-cm path length cuvette. The haem-induced electronic absorption spectroscopic transition of HSA was complete within the time to achieve the sample preparation (, 10 min). Test measurements performed after 2 h excluded slow kinetic effects.
Binding of ibuprofen and warfarin to ferrous HSA-haem-NO was followed by X-band EPR spectroscopy at pH 7.0 in 1.0 Â 10 21 M phosphate buffer plus 1.0 Â 10 21 M NaCl, and 2173 8C. X-band EPR spectra of ferrous HSA-haem-NO (3.0 Â 10 24 M) in the absence and presence of ibuprofen and warfarin (5.0 Â 10 22 M) were collected on a Bruker ESP 300 spectrometer, operating at 9.42 GHz microwave frequency, 100 kHz field modulation, 20 mW microwave power, and 0.10 mT modulation amplitude. The ibuprofen-and warfarin-induced EPR-spectroscopic transition of ferrous HSA -haem-NO was complete within the time to achieve the sample preparation (, 10 min). Test measurements performed after 2 h excluded slow kinetic effects [8] . Fig. 2 shows the electronic absorption spectra of ferric HSA -haem in the absence and presence of ibuprofen and warfarin at pH 7.0 and 25.0 8C. Electronic absorbance spectroscopy and 1 H-NMR relaxometry indicate that the haem iron atom of ferric HSA -haem is hexa-coordinated, possibly being bonded to His105 and Tyr148 as suggested by docking simulations [7] . Upon drug binding, neither a change in the haem-iron atom coordination number, nor in the spin state of the metal centre, is observed. Spectra shown in Fig. 2 are indicative of a high-spin state of the haem-iron. Actually, even the minor low-spin component [22] seems to diminish in the presence of either drug. In fact, the Soret band is blue-shifted, the charge transfer band is red-shifted and the a band is decreased in intensity with respect to the b band. The spectral features shown in Fig. 2 are indicative of a drug-dependent conformational transition(s) that does not affect the inner coordination sphere of the haem iron atom. The electronic absorption spectra were recorded in a 10-cm path length cuvette. For further details, see text.
R E S U L T S A N D D I S C U S S I O N
[23]. In the presence of saturating amounts of ibuprofen and warfarin (5.0 Â 10 22 M) the affinity of haem for HSA decreases by about one order of magnitude, the drugindependent K d value being 1.5^0.2 Â 10 27 M at pH 7.0 and 25.0 8C. In the absence and presence of drugs, the value of n for haem binding to HSA is 1.0^0.1 at pH 7.0 and 25.0 8C (see Fig. 4 ).
Data reported in Figs 3 and 4 indicate that haem binding to HSA inhibits ibuprofen and warfarin association to the warfarin primary cleft (i.e. Sudlow's site I), corresponding to the ibuprofen secondary site [1, 3, 11] . Then, ibuprofen and warfarin impair ferric HSA -haem formation. Remarkably, the ibuprofen primary cleft (i.e. Sudlow's site II) appears to be functionally and spectroscopically uncoupled to the haem site of HSA.
Ferric HSA -haem has been widely investigated by 1 H-NMR relaxometry [7] . The high value of the paramagnetic contribution to the water relaxation rate (R 1p ) of hexacoordinated ferric HSA -haem (¼ 4.8 mM 21 : s 21 at 20 MHz, pH 7.2 and 25 8C) has been ascribed to the occurrence of slowly exchanging water molecules in the surroundings of the paramagnetic ferric haem center [7] . In the presence of saturating amounts of ibuprofen and warfarin, the R 1p value of hexacoordinated ferric HSAhaem decreases to 0.4 mM 21 : s 21 at 20 MHz, pH 7.0 and 25 8C (data not shown). The decrease of the R 1p value upon drug binding may reflect a conformational transition(s) towards a ferric HSA -haem state where slowly exchanging water molecules are far apart from the paramagnetic centre. On the other hand, the lifetime of the ferric haem centre hydration shell could be shortened to approach the diffusion mean time [26] [27] [28] . Fig. 5 shows a ribbon diagram of HSA (PDB code 1E78) [5] . Remarkably, a cavity hosting three water molecules can be located at the interface between the haem cleft and the warfarin primary site (i.e. Sudlow's site I). These water The HSA backbone is rendered as a ribbon model. HSA atomic coordinates were recovered from the Protein Data Bank (PDB ID: 1E78) [19] . For details, see [5, 7, 10, 14] and text. From [8] .
molecules are able to exchange with the bulk solvent typically on the submicrosecond timescale, which is sufficient to promote relaxation of the observed water protons [27] . Therefore, upon drug binding, these water molecules are displaced or, alternatively, their residence lifetime is reduced. In either case, a quenching of the paramagnetic contribution to the observed relaxation rate is expected [7, 24, 26] . Fig. 6 shows the X-band EPR spectra of ferrous HSAhaem-NO in the absence and presence of ibuprofen and warfarin. Ferrous HSA-haem-NO samples obtained by different methods give identical X-band EPR spectra. In the absence of any allosteric effector, the X-band EPR spectrum of ferrous HSA-haem-NO displays a three-line splitting (A 3 ¼ 1.65 mT) in the high magnetic field region (g 3 ¼ 2.010) (see Fig. 6 , spectrum a, and Table 1 ). This X-band EPR spectrum has been associated with the fivecoordinate haem-iron state of ferrous HSA-haem-NO [8] , in agreement with data reported for several ferrous nitrosylated haemoglobin systems [8, [29] [30] [31] [32] [33] [34] . Addition of either ibuprofen or warfarin to ferrous HSA-haem-NO induces the transition towards a species characterized by an X-band EPR spectrum with a rhombic shape and a weak superhyperfine pattern in the g z region (see Fig. 6 , spectrum b, and Table 1 ). Such behaviour is similar to that observed in the presence of bezafibrate and clofibrate, which has been attributed to the shift of the conformational equilibrium towards the six-coordinated haem-iron state of ferrous HSA -haem-NO [8] . The His242 residue has been postulated to be a likely candidate for the sixth axial ligand of the haem iron in ferrous HSA-haem-NO in the presence of bezafibrate and clofibrate [8] . However, more recent results are consistent with the suggestion that His105 might be responsible for the sixth axial bonding of the haem iron [7, 10, 11] . Remarkably, His242 has been shown to be hydrogen-bonded to warfarin [14] . As the binding of warfarin to Sudlow's site I does not affect the coordination state of haem iron (see Fig. 2 ), His242 does not appear to be a likely candidate for the axial haem bonding.
C O N C L U S I O N S
The effect of ibuprofen and warfarin on the electronic absorption spectroscopic, 1 H-NMR relaxometric and X-band EPR spectroscopic properties of ferric HSA -haem and ferrous HSA-haem-NO is in keeping with the allosteric conformational transition(s) induced by these therapeutic drugs in HSA. Note that the Sudlow's site I and the Sudlow's site II ligands induce the N (normal) to B (basic) conformer transition in HSA. Accordingly, the affinity of therapeutic drugs for the B-form of HSA is higher than that observed for the N-form [1, 3, 4, 14, 35, 36] . Haem inhibits drug binding, possibly stabilizing the N-species of HSA (present study). Accordingly, binding of ibuprofen and warfarin to Sudlow's site I impairs ferric HSA -haem formation (present study). Finally, drug-dependent spectroscopic properties of ferric HSA -haem and ferrous HSAhaem-NO may be helpful in investigating ligand binding and allosteric properties of HSA, as already reported for haemoglobin (see [37, 38] ). Therefore, the therapeutic use of warfarin and ibuprofen may affect haem transfer to hemopexin and consequently its plasma level. In parallel, haem may affect pharmacokinetics of drugs carried out by HSA.
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